Hospitalist Doctors in Albemarle, NC Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Stacey Evelyn Furr, FNP Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

Kevin Antonio Lopez-shirley, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Carolinas Hospitalist Group - Stanly, Albemarle, NC 28001 Phone: 704-984-4365    Fax: 704-983-7856

Evelina Kartsimaris, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

Prashant Dhirajlal Bhensdadia, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

Syed Fakruddin Ali Ahmed, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365    Fax: 704-983-7856

Ajay Gupta, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

Marshall Kamau Rashaad Crawford, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

Leonard David Saltzman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1420 Us 52 N, Albemarle, NC 28001 Phone: 704-982-9877    Fax: 704-982-7618

Shailaja Goli, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 301 Yadkin St, Albemarle, NC 28001 Phone: 704-984-4365

News Archive

Retinoblastoma tumor suppressor may predict chemotherapy effectiveness

A common molecular pathway could help physicians predict which lung cancer patients will benefit from chemotherapy drugs, according to new research from a multidisciplinary team at the University of Cincinnati (UC).

Amerigroup second-quarter total revenues increase 11.3% to $1.4 billion

Amerigroup Corporation today announced that net income for the second quarter of 2010 was $67.2 million, or $1.31 per diluted share, versus net income of $49.6 million, or $0.94 per diluted share, for the second quarter of 2009. Second quarter of 2009 results were positively impacted by a tax adjustment of $0.43 per diluted share related to litigation settled in 2008. Excluding the tax adjustment, second quarter of 2009 net income would have been $27.2 million, or $0.51 per diluted share.

Young people who have attempted suicide less likely to have successful professional career later

People who have attempted suicide when young are less likely to have a successful professional career later in life.

FDA grants marketing approval for Elitek

Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.

Mindray DS USA announces the recent appointment of its Vice President

Mindray DS USA, a Mindray Global Company, announces the recent appointment of Michael Thompson as vice president of ultrasound sales for the U.S. Thompson brings more than 20 years of medical sales, sales force management and business development to the position.

Read more Medical News

› Verified 8 days ago